TIN Board of Directors

Steve O’Donnell, Founder & CEO

As someone living with CMT I saw a need to get involved, for both myself and those affected. I wanted to give back to the patient community, and have continued to participate in activities that support goals of the Charcot-Marie-Tooth Association as a Board member. My personal focus and interest is on physical therapy approaches to sustain patient functionally. My goal in founding TIN is to help people stay as fit as possible, both mentally and physically, until we find a cure. I will take personal responsibility to identify and pass along best-in-practice approaches to therapies that can guide and immediately benefit patients, and which can take a place in their self-care program. I will do my best with TIN to align and collaborate with motivated, world-renowned experts in each area of effort we undertake, and will also support promising treatment strategies where there is a clear path to the patient.

I have a Bachelor’s degree in marketing from the University of Maryland, and since had a career as a serial entrepreneur in the Baltimore business community. Currently, I am CEO of a steel distribution business, and President of a real estate building & development company.

DON’T STOP – JUST KEEP MOVING!!

Tom Haslach

I have always believed that charity should truly begin at home – when we do things to care for others, we ought to put these efforts toward our own community. First, to care for those closest to us. Then, if we have more to give, to help causes we do not have a personal connection to.

Steve O’Donnell was the first person I met when I attended the University of Maryland. We became instant friends. He had CMT then, but I did not know it. He never brought attention to it and he never used it as an excuse. After 35 years, I look back at the man and what he has accomplished. I see a person who has poured his heart and soul into everything he does: his family and friends; his business; his community; his support and unwavering resolve to find ways to aid those with CMT. I am proud of the efforts Steve has put forth and equally proud to stand with him in his pursuit of a cure.

I am a shareholder, board member and Chief Development Officer for a national service company. I’ve invested most of my career to the study of human nature and social interactions. Currently I reside in the Atlanta, GA area with my wife Carol. Our two children are away at University.

Steve O’Connell, M.B.A.

I am drawn to the cause of finding a cure for CMT because my friend, Steve O’Donnell, is afflicted with the disease. I have known Steve since our college days at the University of Maryland. I always knew he had issues with his hands and lower legs, but it never slowed him down. When Steve started sponsoring events to raise money to find a cure I began to learn about the CMT that afflicted him. I have always tried to contribute and participate in these events. In 2019 Steve and I hosted a golf event in Baltimore to raise funds and awareness for CMT. Our inaugural event was a great success and introduced a whole new group to the cause.

When Steve asked me to join the Board of TIN I didn’t hesitate to accept. I hope I can be an asset to his endeavors to speed the process of bringing therapies to those with CMT.
I have a finance degree from the University of Maryland and an MBA from The George Washington University. I am currently Senior Vice President & Treasurer at Navient. I live in northern Virginia with my wife and two daughters.

Jimmy Reyes

Steve and I were roommates in college, and I am very familiar with his passion and drive to succeed. I feel fortunate to be part of this team and will bring all that I can to help further his mission of finding therapies and a cure for CMT.

I graduated from the University of Maryland with a degree in Economics, Government, and Politics. I am currently President of Reyes Holdings LLC, ranked by Forbes as the 8th largest privately held company in the United States.

I presently serve as a member of the Research, Education, and Innovation Advisory Board and the CNMC Board for the Children’s National Medical Center in Washington, D.C, and previously served as Chairman of the Board of Directors of the National Rehabilitation Hospital. I was appointed to the University of Virginia’s, Board of Visitors by Governor McAuliffe in 2015 and reappointed by Governor Northam.

I currently reside in Washington, D.C. and Palm Beach, FL, and have two children away at University.

Robert (Bob) Shaffer, Esq.

Having seen everything that Steve has accomplished in life, I was not surprised that he would want to take on yet another and perhaps his greatest challenge so far: finding a cure for CMT, not only for himself but for the 2.8 million others who are afflicted with the disease. It takes a lot of personal courage and commitment to find a cure for any disease, but Steve rarely, if ever, turns down a challenge. I would never bet against Steve, or pass up the opportunity and privilege to have even a small role in this challenge.

I am the General Counsel of Retail Services & Systems, Inc., based in Bethesda, Maryland, which owns the brand name Total Wine & More. Total Wine & More is the nation’s largest independent retailer of alcoholic beverages, with over 8,000 employees in 25 states. I head the Legal and Public and Community Affairs department, and also serve on the executive leadership team. Prior to joining Total Wine & More, I was a trial lawyer specializing in complex commercial litigation in Baltimore and Washington, D.C.

I live in the Baltimore area with my wife Denise (also a lawyer) and have three daughters.

David Todd, M.D., M.H.A.

I have known the O’Donnell family for many years and have personally witnessed their dedicated efforts to manage CMT, and help others to do so as well. I am honored to join this team and contribute my knowledge and guidance to TIN.

I received my Bachelor of Science in Biology from Davidson College in North Carolina, a Master in Healthcare Administration from the University of North Carolina School of Public Health, and medical degree from Albany Medical College. After a Radiology Residency at the University of Maryland Medical Center, and an Interventional Radiology Fellowship at the Johns Hopkins Medical Institute, I joined Annapolis Radiology Associates where I am currently partner. I serve as the Medical Director for Anne Arundel Diagnostics Imaging, and President of the Medical Staff at Anne Arundel Medical Center.

In my free time, I enjoy Jiu Jitsu, travel and movies and live in Annapolis with my wife Betsey and three children.

TIN Advisory Board 

Scott Heinlein, P.T.

I am a Maryland-licensed Physical Therapist with extensive training and experience in manual therapy techniques. I graduated magna cum laude from the University of Maryland, Baltimore with a B.S. in Physical Therapy in 1992. I have developed an interest in helping people with Charcot-Marie Tooth Disease after seeing several patients who presented with orthopedic problems and injuries associated with the underlying neurological damage from CMT.

My aim in working with people with CMT is to keep them safe, independent, and active. I’ve helped to design effective strengthening programs that can be done at home in a short amount of time to help busy people with CMT get the most out of their exercises with the least interruption of their day. I am honored to help the foundation in its endeavor to make helpful information more accessible to CMT-patients everywhere.

Jon Lai, Ph.D.

I am a Professor of Biochemistry at the Albert Einstein College of Medicine in the Bronx, NY, and was born and raised in Edmonton, Alberta, Canada. I received my B.Sc. Hons. in Biochemistry at Queen’s University in Kingston, Canada, and then obtained a Ph.D. in Chemistry and Biophysics at the University of Wisconsin – Madison, working on peptide structure and function, followed by fellowship research at Harvard Medical School in Biological Chemistry, studying enzymology, protein chemistry, and structural virology. I started my independent career in 2007 at Einstein as an Assistant Professor, rising through the ranks to become Full Professor in 2018. I have been recipient of the Arnold and Mabel Young investigator Award (2009), and the Irma T. Hirschl/Monique Weill-Caulier Career Scientist Award (2015).

Rudolf Martini, Ph.D.

I am a University Professor of Neurobiology in the Department of Neurology at the University Hospital of Würzburg (Germany), where I am Head of its Developmental Neurobiology Section. I studied Biology at the University of Karlsruhe (Germany) and received my doctoral degree there in Zoology. I started an independent research laboratory in Würzburg (Germany) following fellowships at the University of Heidelberg (Germany) and at the Swiss Federal Institute of Technology Zürich (Switzerland).

My laboratory is known internationally for its work on the pathogenesis of diseases of the central and peripheral nervous system. The particular emphasis of the research group is on inflammation as a disease amplifier, and the emerging opportunities for treatment related to this. I have received several awards for his work in this area, including the Felix-Jerusalem-Award for neuromuscular disorders, and the Sobek Award for Multiple Sclerosis Research. My research work on CMT disorders goes back to the early 1990’s; this notably includes the recent discovery of a role for the inflammatory cytokine CSF-1 in CMT disease pathogenesis.

My team is currently working with TIN to initiate several new approaches to CMT therapy and treatment.

Wendy Quitasol

Owner and Founder, MindBody PT

I am the founder and owner of Mind Body Physical Therapy & Wellness Center, Inc., a practice that is focused on Physical Therapy (PT) and Wellness. The practice has been shaped by her awareness that PT is often the first step to creating and maintaining a healthy lifestyle. It’s why my team and I focus on achieving a healthy recovery following injury, and on transitioning clients to a fitness routine that helps mitigate and avoid future injury. Importantly, the practice brings together PT and Pilates to place an emphasis on lifelong fitness and wellness. This combined approach impacts a broad and diverse clientele, and is critical for people with CMT to incorporate into their daily life as a means to manage long-term movement issues.

I have worked as a Physical Therapist for more than two decades; this has spanned work at both the Johns Hopkins Hospital and Greater Baltimore Medical Center, and as an independent Physical Therapist. I received my Master’s Degree in Physical Therapy from Temple University and Bachelors of Science from the School of Public Health at Indiana University. My Pilates Training came from one of the original, esteemed founders and teachers of the method, and since then I have taught many continuing education classes for healthcare professionals about integrating Pilates into therapy programs. I also serve as a volunteer for Swim Across America-Baltimore, which has raised over $4.2 million for cancer research since 2009.

E. Richard Stanley, Ph.D.

I am the Renee and Robert A. Belfer Professor of Developmental Biology, and Professor of Developmental and Molecular Biology, at the Albert Einstein College of Medicine in New York. I received my B.Sc. Hons. degree in Biochemistry from the University of Western Australia and Ph.D. in Medical Biology from the University of Melbourne (Australia). Following fellowship work there, I was appointed to the faculty of the Department of Medical Biophysics of the University of Toronto (Canada) in 1972, and joined the faculty of the Albert Einstein College of Medicine in 1977, leading the Department of Developmental and Molecular Biology as its Chair for a number of years. I have received a number of awards for my research, including a Leukemia Society of America Scholar Award, a Hirschl Career Scientist Award, a Markey Charitable Trust Award, the Bonazinga Research Award of the Society for Leukocyte Biology, the E. Donnall Thomas Award of the American Society of Hematology and two NIH Merit Awards.

The work of my research group has notably led to the identification of a growth factor called colony stimulating factor-1 (CSF-1), its receptor (CSF-1R), and the related interleukin-34 (IL-34). The team has worked to define their biological roles in development and disease, for which the lab is considered expert in the field. Recent efforts of the Stanley laboratory have leveraged our knowledge in this area to develop an approach to treat a rare neurological disorder called Adult Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP), an Alzheimer’s disease-like adult-onset dementia in man. The laboratory has notably identified a therapeutic target for ALSP that may also be targeted in other neurodegenerative diseases.

My research team is currently working to develop an immunotherapy for Charcot Marie Tooth Disease Type 1X as part of a TIN-supported team.

Mike Studer, P.T., M.H.S. (Also; NCS, CEEAA, CWT, CSST and FAPTA)

I am the owner and lead therapist at Northwest Rehabilitation Associates in Salem, Oregon. I’ve been a physical therapist since 1991 and a Clinical Specialist in Neurologic Physical Therapy since 1995. I’ve authored over 30 journal articles and 6 book chapters in this subject area, and am recognized nationally and internationally as a speaker on topics including; aging, stroke, motor learning, motivation in rehabilitation, cognition, balance, dizziness, and Parkinson’s disease.

I am the only therapist in the nation to be awarded the Clinician of the Year by two different national academies of the American Physical Therapy Association, receiving the Clinical Excellence Award in both Neurology and Geriatrics. In 2020, I was made a Fellow of the American Physical Therapy Association for lifetime and diverse contributions to the profession in clinical, research and educational fields, the highest honor that can be bestowed on a physical therapist. That year, I was also selected to present a TED talk on neuroplasticity.

Recently, I’ve led the development of instructional physical therapy videos for TIN, with the aim of broadly benefiting CMT patients through their usage.